Strategic partnership will link DNA data with rich clinical data to identify novel biomarkers for targeted cancer therapies The two companies will utilize AI and multimodal molecular data to unlock ...
Guardant's oncology and screening businesses are expanding at a rapid pace. New partnerships should drive further gains. Guardant's third-quarter revenue soared by 39% year over year to $265.2 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results